Literature DB >> 2043955

Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study.

J G Llewelyn1, S G Gilbey, P K Thomas, R H King, J R Muddle, P J Watkins.   

Abstract

Observations have been made on a selected series of insulin-dependent patients with neuropathy, subdivided into three groups: (1) severe autonomic neuropathy with an accompanying painless sensory neuropathy; (2) severe autonomic neuropathy with a chronic painful sensory neuropathy; and (3) chronic or acute painful sensory neuropathy with no autonomic neuropathy. All three groups showed a loss of large and small myelinated nerve fibres in sural nerve biopsy specimens which was greater in Groups 1 and 2. Regenerative activity was prominent in all three groups, but least in Group 3. Teased fibre studies showed evidence both of axonal regeneration and remyelination. Active fibre degeneration was rare. Measurements of g ratio (axon diameter:total fibre diameter) gave no indication of axonal atrophy. The density of unmyelinated axons was reduced in all three groups, as was their median diameter. Vibration sense threshold was positively correlated with the total number of myelinated fibres and thermal sensory threshold with median unmyelinated axon diameter but not with total unmyelinated axon numbers. No correlation between the occurrence of pain and active degeneration of myelinated fibres or with regenerative activity either in myelinated or unmyelinated axons was detectable. Assessment of differential loss of large or small myelinated nerve fibres was difficult because of the presence of large numbers of small regenerating myelinated axons. The results are discussed in relation to the concept of 'diabetic small fibre neuropathy' and the causation of pain in diabetic neuropathy.

Entities:  

Mesh:

Year:  1991        PMID: 2043955     DOI: 10.1093/brain/114.2.867

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  30 in total

1.  Neurological manifestations in chronic mountain sickness: the burning feet-burning hands syndrome.

Authors:  P K Thomas; R H King; S F Feng; J R Muddle; J M Workman; J Gamboa; R Tapia; M Vargas; O Appenzeller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

2.  Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

3.  Freeze-fracture observations on normal and abnormal human perineurial tight junctions: alterations in diabetic polyneuropathy.

Authors:  N G Beamish; C Stolinski; P K Thomas; R H King
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 4.  Painful diabetic neuropathy.

Authors:  S Tesfaye; P Kempler
Journal:  Diabetologia       Date:  2005-05       Impact factor: 10.122

Review 5.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

6.  Epineurial microvasculitis in proximal diabetic neuropathy.

Authors:  J G Llewelyn; P K Thomas; R H King
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

Review 7.  Diabetic neuropathy: an update.

Authors:  G Said
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

8.  Skeletal Muscle Reflex-Induced Sympathetic Dysregulation and Sensitization of Muscle Afferents in Type 1 Diabetic Rats.

Authors:  Rie Ishizawa; Han-Kyul Kim; Norio Hotta; Gary A Iwamoto; Wanpen Vongpatanasin; Jere H Mitchell; Scott A Smith; Masaki Mizuno
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

Review 9.  Clinical observations and experiments in diabetic neuropathy.

Authors:  P J Watkins
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

10.  Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy.

Authors:  G Said; D Baudoin; K Toyooka
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.